Delivery Order SPE2DR25D3103-SPE2DR26F9U19
- Not listed
- The Defense Logistics Agency (DLA) awarded a $7,941.41 delivery order to AmerisourceBergen Drug Corp for HYZAAR 100-12.5 tablets (90-count units) on July 30, 2025, with completion targeted for July 31, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a pharmaceutical supply requirement supporting federal medical procurement...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,464.33 to AmerisourceBergen Drug Corp for the supply of HYZAAR 50-12.5 tablets (90-count units) under a firm fixed price contract. The award was issued on July 18, 2025, with an ultimate completion date of July 21, 2025. This non-set-aside delivery order was competitively awarded and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine...
- The Defense Logistics Agency awarded a delivery order valued at $1,504.02 to AmerisourceBergen Drug Corp for the supply of HYZAAR 50-12.5 tablets (30-count units). This competitive award, issued on July 30, 2025, with an ultimate completion date of July 31, 2025, represents a firm fixed-price transaction with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a $2,889.30 delivery order to AmerisourceBergen Drug Corp for HYZAAR 50-12.5 tablet medication (30-count supply), with an ultimate completion date of July 24, 2025. This is a firm fixed-price, non-set-aside contract performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving the federal medical procurement sector, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $5,776.16 to AmerisourceBergen Drug Corp for the supply of HYZAAR 50-12.5 tablets in quantities of 30, with a firm fixed price contract type and an ultimate completion date of December 9, 2025. This award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026. The contract was...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $6,539.90 to supply HYZAAR 50-12.5 tablets (30-count units) with a firm fixed price contract type. The award, issued on November 7, 2025, with an ultimate completion date of November 10, 2025, represents a non-set-aside competitive award. The place of performance is the company's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $2,237.52 delivery order to AmerisourceBergen Drug Corp for HYZAAR 50-12.5 tablets (30-count packages) on November 13, 2025, with an ultimate completion date of November 14, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. The work will be performed...
- The Defense Logistics Agency awarded a $3,928.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for HYZAAR 50-12.5 tablets (30 count) on September 8, 2025, with an ultimate completion date of September 9, 2025. This is a non-set-aside, competitively awarded contract supporting federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for military and veteran healthcare systems...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of HYZAAR 50-12.5 tablets (30-count units) valued at $2,083.81, with an ultimate completion date of September 29, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion comprehensive global...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for HYZAAR 50-12.5 tablets (a combination antihypertensive medication) in the quantity of 30 units, with a ceiling value of $1,059.30. This competitively awarded, firm fixed-price delivery order was executed on August 11, 2025, with an ultimate completion date of August 12, 2025. The contract is classified as a child award, indicating it derives from a larger contract vehicle. AmerisourceBergen Drug Corp, a...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9U19Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,596.31 to AmerisourceBergen Drug Corp for the supply of HYZAAR 100-12.5 mg tablets (30-count units), with an ultimate completion date of January 5, 2026. This non-set-aside, competitively awarded contract employs firm fixed pricing and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), a $999.999 billion prime contract vehicle valued through December 2026 that serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a significant position within the federal medical supply chain, particularly for Defense Health Agency and other government healthcare systems. This delivery order represents a routine pharmaceutical procurement supporting military healthcare operations, consistent with the contractor's extensive portfolio of federal medical product deliveries spanning diabetes medications, neurological treatments, pain management pharmaceuticals, and specialized medical supplies. The firm fixed pricing structure and competitive award designation reflect standard federal procurement practices within the DLA's pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 1/1/26 |